- Home
- ARQ vs NBTX Comparison
ARQ vs NBTX Comparison
Compare ARQ & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQ
- NBTX
- Stock Information
- Founded
- ARQ 1996
- NBTX 2003
- Country
- ARQ United States
- NBTX France
- Employees
- ARQ N/A
- NBTX N/A
- Industry
- ARQ
- NBTX Biotechnology: Pharmaceutical Preparations
- Sector
- ARQ
- NBTX Health Care
- Exchange
- ARQ NYSE
- NBTX Nasdaq
- Market Cap
- ARQ 249.0M
- NBTX 201.9M
- IPO Year
- ARQ N/A
- NBTX 2020
- Fundamental
- Price
- ARQ $6.89
- NBTX $3.89
- Analyst Decision
- ARQ
- NBTX Strong Buy
- Analyst Count
- ARQ 0
- NBTX 2
- Target Price
- ARQ N/A
- NBTX $11.50
- AVG Volume (30 Days)
- ARQ 242.2K
- NBTX 7.6K
- Earning Date
- ARQ 11-07-2024
- NBTX 11-26-2024
- Dividend Yield
- ARQ N/A
- NBTX N/A
- EPS Growth
- ARQ N/A
- NBTX N/A
- EPS
- ARQ N/A
- NBTX N/A
- Revenue
- ARQ $110,023,000.00
- NBTX $45,220,186.00
- Revenue This Year
- ARQ $6.31
- NBTX N/A
- Revenue Next Year
- ARQ $31.95
- NBTX N/A
- P/E Ratio
- ARQ N/A
- NBTX N/A
- Revenue Growth
- ARQ 16.44
- NBTX 526.17
- 52 Week Low
- ARQ $2.31
- NBTX $3.83
- 52 Week High
- ARQ $8.26
- NBTX $8.96
- Technical
- Relative Strength Index (RSI)
- ARQ 65.39
- NBTX 40.72
- Support Level
- ARQ $6.54
- NBTX $3.83
- Resistance Level
- ARQ $7.21
- NBTX $4.55
- Average True Range (ATR)
- ARQ 0.27
- NBTX 0.23
- MACD
- ARQ 0.09
- NBTX -0.02
- Stochastic Oscillator
- ARQ 78.81
- NBTX 30.86
About ARQ ARQ INC
Arq Inc is an environmental technology company principally engaged in the sale of consumable air, water, and soil treatment solutions including activated carbon (AC) and chemical technologies. The company manufactures and sells activated carbon and other chemicals used to capture and remove contaminants for the coal-fired power generation, industrial, municipal water and air, water and soil treatment and remediation markets. Some of the products in its portfolio are Powdered Activated Carbon, Granular Activated Carbon, and Colloidal Carbon Product among others.
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.